Translocation of a gut pathobiont drives autoimmunity in mice and humans
- PMID: 29590047
- PMCID: PMC5959731
- DOI: 10.1126/science.aar7201
Translocation of a gut pathobiont drives autoimmunity in mice and humans
Erratum in
-
Erratum for the Report "Translocation of a gut pathobiont drives autoimmunity in mice and humans" by S. Manfredo Vieira, M. Hiltensperger, V. Kumar, D. Zegarra-Ruiz, C. Dehner, N. Khan, F. R. C. Costa, E. Tiniakou, T. Greiling, W. Ruff, A. Barbieri, C. Kriegel, S. S. Mehta, J. R. Knight, D. Jain, A. L. Goodman, M. A. Kriegel.Science. 2018 May 4;360(6388):eaat9922. doi: 10.1126/science.aat9922. Science. 2018. PMID: 29724927 No abstract available.
Abstract
Despite multiple associations between the microbiota and immune diseases, their role in autoimmunity is poorly understood. We found that translocation of a gut pathobiont, Enterococcus gallinarum, to the liver and other systemic tissues triggers autoimmune responses in a genetic background predisposing to autoimmunity. Antibiotic treatment prevented mortality in this model, suppressed growth of E. gallinarum in tissues, and eliminated pathogenic autoantibodies and T cells. Hepatocyte-E. gallinarum cocultures induced autoimmune-promoting factors. Pathobiont translocation in monocolonized and autoimmune-prone mice induced autoantibodies and caused mortality, which could be prevented by an intramuscular vaccine targeting the pathobiont. E. gallinarum-specific DNA was recovered from liver biopsies of autoimmune patients, and cocultures with human hepatocytes replicated the murine findings; hence, similar processes apparently occur in susceptible humans. These discoveries show that a gut pathobiont can translocate and promote autoimmunity in genetically predisposed hosts.
Trial registration: ClinicalTrials.gov NCT02394964.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures




Comment in
-
Intestinal barriers protect against disease.Science. 2018 Mar 9;359(6380):1097-1098. doi: 10.1126/science.aat0835. Science. 2018. PMID: 29590026 No abstract available.
-
Systemic lupus erythematosus: Escape of gut microbe to the liver drives autoimmunity.Nat Rev Rheumatol. 2018 May;14(5):247. doi: 10.1038/nrrheum.2018.53. Epub 2018 Apr 5. Nat Rev Rheumatol. 2018. PMID: 29618811 No abstract available.
-
A Hen in the Wolf Den: A Pathobiont Tale.Immunity. 2018 Apr 17;48(4):628-631. doi: 10.1016/j.immuni.2018.04.003. Immunity. 2018. PMID: 29669247
-
The Microbiome and Systemic Lupus Erythematosus.N Engl J Med. 2018 Jun 7;378(23):2236-2237. doi: 10.1056/NEJMcibr1804368. N Engl J Med. 2018. PMID: 29874543 No abstract available.
Similar articles
-
Translocating gut pathobiont Enterococcus gallinarum induces TH17 and IgG3 anti-RNA-directed autoimmunity in mouse and human.Sci Transl Med. 2025 Feb 5;17(784):eadj6294. doi: 10.1126/scitranslmed.adj6294. Epub 2025 Feb 5. Sci Transl Med. 2025. PMID: 39908347
-
Mechanisms and consequences of gut commensal translocation in chronic diseases.Gut Microbes. 2020;11(2):217-230. doi: 10.1080/19490976.2019.1629236. Epub 2019 Jul 15. Gut Microbes. 2020. PMID: 31306081 Free PMC article. Review.
-
Friend or foe? Lactobacillus in the context of autoimmune disease.Adv Immunol. 2020;146:29-56. doi: 10.1016/bs.ai.2020.02.002. Epub 2020 Mar 19. Adv Immunol. 2020. PMID: 32327152 Review.
-
Human Th17- and IgG3-associated autoimmunity induced by a translocating gut pathobiont.bioRxiv [Preprint]. 2023 Jul 1:2023.06.29.546430. doi: 10.1101/2023.06.29.546430. bioRxiv. 2023. PMID: 37425769 Free PMC article. Preprint.
-
Gut microbiota translocation promotes autoimmune cholangitis.J Autoimmun. 2018 Dec;95:47-57. doi: 10.1016/j.jaut.2018.09.010. Epub 2018 Oct 17. J Autoimmun. 2018. PMID: 30340822 Free PMC article.
Cited by
-
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy.Front Immunol. 2021 Feb 10;11:620170. doi: 10.3389/fimmu.2020.620170. eCollection 2020. Front Immunol. 2021. PMID: 33643302 Free PMC article. Review.
-
An Intestinal Microbiome Intervention Affects Biochemical Disease Activity in Patients with Antiphospholipid Syndrome.TH Open. 2024 Aug 5;8(3):e308-e316. doi: 10.1055/s-0044-1788653. eCollection 2024 Jul. TH Open. 2024. PMID: 39105064 Free PMC article.
-
Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota.Heliyon. 2024 Jul 27;10(15):e35336. doi: 10.1016/j.heliyon.2024.e35336. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170494 Free PMC article. Review.
-
Vaccine therapy for dysbiosis-related diseases.World J Gastroenterol. 2020 Jun 7;26(21):2758-2767. doi: 10.3748/wjg.v26.i21.2758. World J Gastroenterol. 2020. PMID: 32550752 Free PMC article. Review.
-
Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity.Toxicol Appl Pharmacol. 2021 Aug 1;424:115597. doi: 10.1016/j.taap.2021.115597. Epub 2021 May 27. Toxicol Appl Pharmacol. 2021. PMID: 34051218 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical